Slingshot Insights

Catalyst

Slingshot members are tracking this event:

Allergan (AGN) Completes Acquisition of AqueSys and XEN45 for $300 Million

Source Link:: http://www.allergan.com/news/news/thomson-reuters/allergan-successfully-completes-aquesys-acquisitio

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

PFE

100%

AGN

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details - XEN45 Approved in Global Markets; In Late-Stage Development in the U.S. -- -- Adds to Allergan's Leading Development and Commercialization Position in Glaucoma --

http://www.allergan....

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Oct 19, 2015

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Ocular Implants, Glaucoma, Xen45